Journal article
840TiP Stereotactic ablative radiotherapy (SABR) for oligoprogressive metastatic castration-resistant prostate cancer (mCRPC) during abiraterone therapy: A phase I study
Authors
Emmenegger U; Cheng S; Zukotynski K; Cheung P
Journal
Annals of Oncology, Vol. 28, ,
Publisher
Elsevier
Publication Date
September 1, 2017
DOI
10.1093/annonc/mdx370.057
ISSN
0923-7534